Advertisements



EcoR– Capital, LLC Buys CytomX Therapeutics Inc, Cascadian Therapeutics Inc, Fate ...

Related Stocks: ACRS, LIFE, ATRA, BMY, CTMX, CASC, FATE, OVAS, JNCE, RGLS, F,.....»»

Category: personnelSource: nytMay 19th, 2017

Boxer Capital, LLC Buys Macrogenics Inc, G– Therapeutics Inc, iPath S&P 5…… VIX Short ...

Related Stocks: LJPC, SNSS, SGEN, MGNX, GTHX, VXX, ALNY, ALXN, ALDX, ANAB, A,.....»»

Category: personnelSource: nytAug 14th, 2017

Armistice Capital, Llc Buys Novelion Therapeutics Inc, Regeneron Pharmaceuticals Inc, Adamas ...

Related Stocks: VNDA, FRPT, NOMD, SGYP, KATE, DECK, NVLN, REGN, ADMS, HBI, T,.....»»

Category: worldSource: nytMay 15th, 2017

Abingworth LLP Buys Cascadian Therapeutics Inc, Aurinia Pharmaceuticals Inc, Immune Design ...

Related Stocks: IMDZ, CASC, AUPH, DRNA,.....»»

Category: blogSource: gurufocusMay 15th, 2017

Rubric Capital Management LP Buys Xperi, Braskem SA, Heron Therapeutics, Sells Olin, Signet ...

Related Stocks: BAK, HRTX, KRA, CNDT, GMS, MDCA, XPER, GPK, BYD, HRI, SNCR, R,.....»»

Category: personnelSource: nytApr 28th, 2017

Fate Therapeutics initiated with a Buy at Roth Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallSep 22nd, 2016

Novo A Buys Dermira Inc, Verona Pharma PLC, Akebia Therapeutics Inc, Sells iRhythm Technologies ...

Related Stocks: DERM, AKBA, VRNA, RETA, IRTC, OPK,.....»»

Category: personnelSource: nytAug 16th, 2017

Fate Therapeutics" (FATE) CEO Scott Wolchko on Q2 2017 Results - Earnings Call Transcript

Fate Therapeutics" (FATE) CEO Scott Wolchko on Q2 2017 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 15th, 2017

Cascadian Therapeutics" (CASC) CEO Scott Myers On Q2 2017 Results - Earnings Call Transcript

Cascadian Therapeutics" (CASC) CEO Scott Myers On Q2 2017 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 8th, 2017

13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EX.....»»

Category: topSource: insidermonkeyAug 8th, 2017

CytomX Therapeutics" (CTMX) CEO Sean McCarthy on Q2 2017 Results - Earnings Call Transcript

CytomX Therapeutics" (CTMX) CEO Sean McCarthy on Q2 2017 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 7th, 2017

13G Filing: Biotechnology Value Fund LP and CytomX Therapeutics Inc (CTMX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 13 – SEC Filing  UNITED STATES SECURITIES AN.....»»

Category: topSource: insidermonkeyJul 4th, 2017

13D Filing: Sarissa Capital Management and Novelion Therapeutics Inc. (NVLN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 7 – SEC Filing CUSIP No.  67001K202 Pa.....»»

Category: topSource: insidermonkeyJul 4th, 2017

Wall Street"s M&A Chatter From June 20: Calpine, Parexel, Gilead, Spherix-Hoth Therapeutics, Norsat-Hytera

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday, June 20, 2017. PAREXEL to be Acquired for $88.10/Share Cash by Pamplona Capital The Deal: read more.....»»

Category: blogSource: benzingaJun 21st, 2017

CytomX Therapeutics Enters Oversold Territory (CTMX)

Dividend Channel.....»»

Category: topSource: redinewsJun 8th, 2017

13G Filing: Adage Capital Management and Sangamo Therapeutics Inc (SGMO)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing SECURITIES AND EXCHANGE C.....»»

Category: topSource: insidermonkeyJun 5th, 2017

13G Filing: Adage Capital Management and Protagonist Therapeutics Inc (PTGX)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing SECURITIES AND EXCHANGE C.....»»

Category: topSource: insidermonkeyJun 1st, 2017

13G Filing: EcoR1 Capital and Regulus Therapeutics Inc. (RGLS)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 7 – SEC Filing UNITED STATES SECURITIES AND E.....»»

Category: topSource: insidermonkeyJun 1st, 2017

13G Filing: Armistice Capital and Novelion Therapeutics Inc. (NVLN)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND .....»»

Category: topSource: insidermonkeyMay 24th, 2017

Halozyme Therapeutics, Inc."s Necessary Move Sends Shares Down as Much as 10%

The need for fresh capital is a plight most drug developers face......»»

Category: topSource: foxnewsMay 19th, 2017

Should CytomX Therapeutics (CTMX) Be On Your Radar Now?

CytomX Therapeutics (CTMX) seems to be overlooked by shareholders .....»»

Category: topSource: zacksMay 16th, 2017